Han JC, Lawlor DA, Kimm SY. Childhood obesity. Lancet. 2010;375(9727):1737–48.
Craig R, Mindell J, Boodhna G. Health survey for England, 2013. 2014.
Ogden CL, Carroll MD, Fryar CD, Flegal KM. Prevalence of obesity among adults and youth: United States, 2011–2014. NCHS Data Brief 2015;(219):1–8.
Suchindran C, North KE, Popkin BM, et al. Association of adolescent obesity with risk of severe obesity in adulthood. JAMA. 2010;304(18):2042–7.
Welbourn R, le Roux CW, Owen-Smith A, et al. Why the NHS should do more bariatric surgery; how much should we do? BMJ. 2016;353:i1472.
Oude Luttikhuis H, Baur L, Jansen H, et al. Interventions for treating obesity in children. Cochrane Database Syst Rev. 2009;1(1)
Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366(17):1567–76.
Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. System Rev. 2015;4(1):1.
Alves JGB, Galé CR, Souza E, et al. Effect of physical exercise on bodyweight in overweight children: a randomized controlled trial in a Brazilian slum. Cadernos de Saúde Pública. 2008;24:s353–9.
Higgins JP, Altman DG, Gotzsche PC, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.
Higgins J, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–58.
Taylor RW, Cox A, Knight L, et al. A tailored family-based obesity intervention: a randomized trial. Pediatrics. 2015;136(2):281–9.
Kokkvoll A, Grimsgaard S, Steinsbekk S, et al. Health in overweight children: 2-year follow-up of Finnmark Activity School—a randomised trial. Arch Dis Child. 2015;100(5):441–8.
Shalitin S, Ashkenazi-Hoffnung L, Yackobovitch-Gavan M, et al. Effects of a twelve-week randomized intervention of exercise and/or diet on weight loss and weight maintenance, and other metabolic parameters in obese preadolescent children. Horm Res. 2009;72(5):287–301.
Okely AD, Collins CE, Morgan PJ, et al. Multi-site randomized controlled trial of a child-centered physical activity program, a parent-centered dietary-modification program, or both in overweight children: the HIKCUPS study. J Pediatr. 2010;157(3):388–94. e1
Ebbeling CB, Leidig MM, Sinclair KB, et al. A reduced–glycemic load diet in the treatment of adolescent obesity. Arch Pediatr Adolesc Med. 2003;157(8):773–9.
Kalarchian MA, Levine MD, Arslanian SA, et al. Family-based treatment of severe pediatric obesity: randomized, controlled trial. Pediatrics. 2009;124(4):1060–8.
Weigel C, Kokocinski K, Lederer P, et al. Childhood obesity: concept, feasibility, and interim results of a local group-based, long-term treatment program. J Nutr Educ Behav. 2008;40(6):369–73.
Nwosu BU, Maranda L, Cullen K, et al. A randomized, double-blind, placebo-controlled trial of adjunctive metformin therapy in overweight/obese youth with type 1 diabetes. PLoS One. 2015;10(9):e0137525.
Wilson DM, Abrams SH, Aye T, et al. Metformin extended release treatment of adolescent obesity: a 48-week randomized, double-blind, placebo-controlled trial with 48-week follow-up. Arch Pediatr Adolesc Med. 2010;164(2):116–23.
Chanoine J, Hampl S, Jensen C, et al. Effect of orlistat on weight and body composition in obese adolescents: a randomized controlled trial. JAMA. 2005;293(23):2873–83.
Ozkan B, Bereket A, Turan S, et al. Addition of orlistat to conventional treatment in adolescents with severe obesity. Eur J Pediatr. 2004;163(12):738–41.
Vandenplas Y, Bollen P, De Langhe K, et al. Intragastric balloons in adolescents with morbid obesity. Eur J Gastroenterol Hepatol. 1999;11(3):243–5.
Curran J, Kalic R, Sherrington C, et al. RCT of intragastric balloons in adolescents: preliminary data. Obes Res Clin Pract. 2011;5:24–5.
De Peppo F, Adorisio O, Melissa B, et al. BioEnterics Intragastric Balloon for the treatment of pathologic obesity in Prader–Willi patients. Paediatr Child Health. 2009;19:S38–42.
Kotnik P, Homan M, Battelino T. Initial experience with endoscopically placed duodenal-jejunal bypass liner (Endobarrier) in morbidly obese adolescents. 2015.
Holterman A, Browne A, Tussing L, et al. A prospective trial for laparoscopic adjustable gastric banding in morbidly obese adolescents: an interim report of weight loss, metabolic and quality of life outcomes. J Pediatr Surg. 2010;45(1):74–9.
Nadler EP, Youn HA, Ginsburg HB, et al. Short-term results in 53 US obese pediatric patients treated with laparoscopic adjustable gastric banding. J Pediatr Surg. 2007;42(1):137–42.
Nadler EP, Youn HA, Ren CJ, et al. An update on 73 US obese pediatric patients treated with laparoscopic adjustable gastric banding: comorbidity resolution and compliance data. J Pediatr Surg. 2008;43(1):141–6.
Nadler EP, Reddy S, Isenalumhe A, et al. Laparoscopic adjustable gastric banding for morbidly obese adolescents affects android fat loss, resolution of comorbidities, and improved metabolic status. J Am Coll Surg. 2009;209(5):638–44.
Silva GM, Osório A, Pereira F, et al. Effect of laparoscopic adjustable gastric banding on modifiable cardiovascular risk factors in extremely obese adolescents. Obes Surg. 2012;22(6):991–4.
Dillard 3rd BE, Gorodner V, Galvani C, et al. Initial experience with the adjustable gastric band in morbidly obese US adolescents and recommendations for further investigation. J Pediatr Gastroenterol Nutr. 2007;45(2):240–6.
Angrisani L, Favretti F, Furbetta F, et al. Obese teenagers treated by Lap-Band System: the Italian experience. Surgery. 2005;138(5):877–81.
Silberhumer GR, Miller K, Kriwanek S, et al. Laparoscopic adjustable gastric banding in adolescents: the Austrian experience. Obes Surg. 2006;16(8):1062–7.
Khen-Dunlop N, Dabbas M, De Filippo G, et al. Primordial influence of post-operative compliance on weight loss after adolescent laparoscopic adjustable gastric banding. Obes Surg. 2016;26(1):98–104.
DuCoin C, Moon RC, Mulatre M, et al. Safety and effectiveness of Roux-en-Y gastric bypass in patients between the ages of 17 and 19. Obes Surg. 2015;25(3):464–9.
Olbers T, Gronowitz E, Werling M, et al. Two-year outcome of laparoscopic Roux-en-Y gastric bypass in adolescents with severe obesity: results from a Swedish Nationwide Study (AMOS). Int J Obes. 2012;36(11):1388–95.
Teeple E, Teich S, Schuster D, et al. Early metabolic improvement following bariatric surgery in morbidly obese adolescents. Pediatr Blood Cancer. 2012;58(1):112–6.
Tsamis D, Plastiras A, Natoudi M, et al. Impact of laparoscopic sleeve gastrectomy on weight loss and associated comorbidities in adolescents and young adults. J Laparoendosc Adv Surg Tech. 2015;25(12):971–5.
Alqahtani AR, Antonisamy B, Alamri H, et al. Laparoscopic sleeve gastrectomy in 108 obese children and adolescents aged 5 to 21 years. Ann Surg. 2012;256(2):266–73.
Alqahtani A, Elahmedi M, Qahtani AR. Laparoscopic sleeve gastrectomy in children younger than 14 years: refuting the concerns. Ann Surg. 2016;263(2):312–9.
Alqahtani AR, Elahmedi MO. Pediatric bariatric surgery: the clinical pathway. Obes Surg. 2015;25(5):910–21.
Widhalm K, Fritsch M, Widhalm H, et al. Bariatric surgery in morbidly obese adolescents: long-term follow-up. Pediatr Obes. 2011;6(S1):65–9.
Widhalm K, Dietrich S, Prager G, et al. Bariatric surgery in morbidly obese adolescents: a 4-year follow-up of ten patients. Pediatr Obes. 2008;3(S1):78–82.
Olbers T, Beamish AJ, Gronowitz E, et al. Laparoscopic Roux-en-Y gastric bypass in adolescents with severe obesity (AMOS): a prospective, 5-year, Swedish nationwide study. Lancet Diabetes Endocrinol. 2017;5(3):174–83.
Inge TH, Courcoulas AP, Jenkins TM, et al. Weight loss and health status 3 years after bariatric surgery in adolescents. N Engl J Med. 2016;374(2):113–23.
Reisler G, Tauber T, Afriat R, et al. Sibutramine as an adjuvant therapy in adolescents suffering from morbid obesity. Isr Med Assoc J. 2006;8(1):30.
Coles N, Birken C, Hamilton J. Emerging treatments for severe obesity in children and adolescents. BMJ. 2016;354:i4116.
Boland CL, Harris JB, Harris KB. Pharmacological management of obesity in pediatric patients. Ann Pharmacother. 2015;49(2):220–32.
Imaz I, Martínez-Cervell C, García-Álvarez EE, et al. Safety and effectiveness of the intragastric balloon for obesity. A meta-analysis. Obes Surg. 2008;18(7):841–6.
Schouten R, Rijs CS, Bouvy ND, et al. A multicenter, randomized efficacy study of the EndoBarrier Gastrointestinal Liner for presurgical weight loss prior to bariatric surgery. Ann Surg. 2010;251(2):236–43.
Black J, White B, Viner R, et al. Bariatric surgery for obese children and adolescents: a systematic review and meta-analysis. Obes Rev. 2013;14(8):634–44.
Malaki M. Sibutramine: a banned innocent antiobesity drug. J Pharm Negat Results. 2016;7(1):53.
James WPT, Caterson ID, Coutinho W, et al. Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects. N Engl J Med. 2010;363(10):905–17.
Shapira B, Goldstein L, Reshef A, et al. A rare case of psychomotor disturbances linked to the use of an adulterated dietary supplement containing sibutramine. Clin Neuropharmacol. 2016;39(3):154–6.
Gibson LJ, Peto J, Warren JM, et al. Lack of evidence on diets for obesity for children: a systematic review. Int J Epidemiol. 2006;35(6):1544–52.
Partsalaki I, Karvela A, Spiliotis BE. Metabolic impact of a ketogenic diet compared to a hypocaloric diet in obese children and adolescents. J Pediatr Endocrinol Metab. 2012;25(7–8):697–704.
Reeves B, Deeks J, Higgins J, Wells G., on behalf of the Cochrane Non-Randomised Studies Methods Group. Chapter 13: including non-randomized studies. Cochrane handbook for systematic reviews of interventions.Version 2008;5(0).
Freedman DS, Sherry B. The validity of BMI as an indicator of body fatness and risk among children. Pediatrics. 2009;124(Suppl 1):S23–34.
McGovern L, Johnson JN, Paulo R, et al. Treatment of pediatric obesity: a systematic review and meta-analysis of randomized trials. J Clin Endocrinol Metab. 2008;93(12):4600–5.
McDonagh MS, Selph S, Ozpinar A, et al. Systematic review of the benefits and risks of metformin in treating obesity in children aged 18 years and younger. JAMA Pediatr. 2014;168(2):178–84.
O’Brien PE, Sawyer SM, Laurie C, et al. Laparoscopic adjustable gastric banding in severely obese adolescents: a randomized trial. JAMA. 2010;303(6):519–26.